Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05327894
Title	Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia (Interfant-21)
Acronym	Interfant-21
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Princess Maxima Center for Pediatric Oncology
Indications	acute biphenotypic leukemia B-lymphoblastic leukemia/lymphoma
Therapies	Blinatumomab
Age Groups:	child
Covered Countries	SWE \| SVK \| NOR \| NLD \| LTU \| ITA \| IRL \| HUN \| FRA \| FIN \| ESP \| DNK \| DEU \| CZE \| BEL \| AUT \| AUS \| ARG